ArticleInternational journal of women's health2026
Diffuse Uterine Leiomyomatosis: A Retrospective Study of Clinical Features and Outcomes in Nine Cases with Literature Review.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Diffuse uterine leiomyomatosis (DUL) is a rare variant of uterine leiomyomas, characterized by ill-defined, cobblestone-like nodules throughout the myometrium, frequently associated with menorrhagia, anemia, and infertility. This study aimed to analyze the clinical features, diagnostic approaches, treatment strategies, and prognostic outcomes of DUL. Patients and Methods: We enrolled nine DUL patients diagnosed via imaging or intraoperative confirmation, who were admitted to the Women's Hospital of Nanjing Medical University between January 2020 and April 2024. We retrospectively collected and analyzed their clinical data, including symptoms, diagnostic methods, treatments, and follow-up outcomes. Results: Mean age at onset was 26.67±4.35 years (18-33 years). Eight cases (88.89%) mainly presented with menorrhagia, seven of which were accompanied by anemia (77.78%). Pelvic magnetic resonance imaging (MRI) indicated DUL in eight cases (88.89%). All patients underwent surgery, four (44.44%) received total abdominal/laparoscopic hysterectomy, four (44.44%) underwent transabdominal myomectomy, and one (11.11%) underwent laparoscopic myomectomy. During a mean follow-up of 53.22±19.19 months (25-76 months), and all patients exhibited significant symptom improvement. Of the five patients who received fertility-preserving surgery, one patient (20.00%) developed MRI-documented recurrence of DUL 42 months after surgery, followed by subsequent total hysterectomy; one patient developed irregular menstrual bleeding 45 months postoperatively and was subsequently treated with gonadotropin-releasing hormone agonist (GnRHa). The remaining three patients had small leiomyomas detected by gynecological ultrasound, but no clinical recurrence of symptoms was observed. Among these three patients, one achieved full-term pregnancy; the remaining two patients had no immediate fertility plans. Conclusion: DUL is associated with early onset and anemia, and appears to carry a risk of recurrence following fertility-sparing surgery. Imaging (particularly MRI) is the primary diagnostic method, and DUL should be distinguished from common multiple uterine fibroids. Hysterectomy is the standard treatment for non-fertility cases, while myomectomy or resection of diffuse lesions is recommended for fertility preservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.